Literature DB >> 7897345

Identification of human papillomavirus seroconversions.

A Wikström1, G J van Doornum, W G Quint, J T Schiller, J Dillner.   

Abstract

The temporal relationship between primary genital human papillomavirus (HPV) infections and the induction of antibodies against viral antigens has not been established. In order to address this question we studied a cohort of 110 women and 48 men with multiple heterosexual partners, who were followed for 220 person-years during which they made 583 visits to the sexually transmitted diseases clinic of the Amsterdam Public Health Service. At each visit spatula or brush samples from multiple anogenital and oral sites were collected for HPV DNA analysis by PCR. Serum samples were also collected and analysed for serological reactivity to peptides derived from the L1, L2 and E2 regions of HPV types 6, 16 and 18 as well as to bovine papillomavirus and HPV-16 virus-like particles. Seroconversions for at least three antigens were found among 16/158 patients. Of these, 10/16 were HPV-positive and in 5/16 cases seroconversions occurred concomitantly with the detection of HPV DNA. Analysis of participants who were HPV-negative at entry, but became HPV DNA-positive during follow-up revealed that antibodies against several HPV antigens were regularly induced at the time of a new HPV infection, in particular the IgG responses against HPV-16 virus-like particles and against the HPV-16 E2-derived peptide 245. Whereas the responses induced among the women with new HPV-16 infection tended to continuously increase, the responses among the men with any type of new HPV infection were mostly transient and disappeared during follow-up. In conclusion, we find that antibody responses to multiple viral antigens are often induced following the detection of genital HPV infection, that the type-specificity of the response is limited and that transient responses are common.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7897345     DOI: 10.1099/0022-1317-76-3-529

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

Review 1.  The role of vaccines in the control of STDs: HPV vaccines.

Authors:  I H Frazer
Journal:  Genitourin Med       Date:  1996-12

2.  Seropositivity against HPV 16 capsids: a better marker of past sexual behaviour than presence of HPV DNA.

Authors:  A O Olsen; J Dillner; K Gjøen; P Magnus
Journal:  Genitourin Med       Date:  1997-04

3.  Generation and characterization of neutralizing monoclonal antibodies against baculo-expressed HPV 16 VLPs.

Authors:  P Vidyasagar; V N Sridevi; S Rajan; A Praveen; A Srikanth; G Abhinay; V Siva Kumar; R R Verma; L Rajendra
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2014-03-14

4.  Immunoglobulin A, G, and M responses to L1 and L2 capsids of human papillomavirus types 6, 11, 16, 18, and 33 L1 after newly acquired infection.

Authors:  G van Doornum; M Prins; A Andersson-Ellström; J Dillner
Journal:  Sex Transm Infect       Date:  1998-10       Impact factor: 3.519

5.  Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women.

Authors:  R P Viscidi; K L Kotloff; B Clayman; K Russ; S Shapiro; K V Shah
Journal:  Clin Diagn Lab Immunol       Date:  1997-03

6.  Attack rates of human papillomavirus type 16 and cervical neoplasia in primiparous women and field trial designs for HPV16 vaccination.

Authors:  M Kibur; V af Geijerstamm; E Pukkala; P Koskela; T Luostarinen; J Paavonen; J Schiller; Z Wang; J Dillner; M Lehtinen
Journal:  Sex Transm Infect       Date:  2000-02       Impact factor: 3.519

7.  Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts.

Authors:  K Hong; C E Greer; N Ketter; G Van Nest; X Paliard
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA.

Authors:  Z Wang; B G Hansson; O Forslund; L Dillner; M Sapp; J T Schiller; B Bjerre; J Dillner
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

9.  Identification of B-cell epitopes on virus-like particles of cutaneous alpha-human papillomaviruses.

Authors:  Tilo Senger; Maria R Becker; Lysann Schädlich; Tim Waterboer; Lutz Gissmann
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

Review 10.  Laboratory and clinical aspects of human papillomavirus testing.

Authors:  Paul K S Chan; María Alejandra Picconi; Tak Hong Cheung; Lucia Giovannelli; Jong Sup Park
Journal:  Crit Rev Clin Lab Sci       Date:  2012 Jul-Aug       Impact factor: 6.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.